CasLoc logo
All Cases PTAB Litigations UPC Oppositions

UCB Inc. v. Teva Pharmaceuticals USA Inc.

1:13-cv-01148

Overview

Case Number 1:13-cv-01148
Filing Date 2013-06-28
Status Terminated
Termination Date 2014-01-24
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceutical Industries Ltd Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

7 Attorneys Listed

Samuel S. Park

UNDELIVERABLE EMAIL 10/31/2018

Michael K. Nutter

Email: mnutter@winston.com

John K. Hsu

Email: jhsu@schiffhardin.com

Eimeric Reig-Plessis

Email: ereigplessis@winston.com

Charles B. Klein

Email: cklein@winston.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Harris FRC Corporation NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Research Corporation Technologies Inc. NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

UCB Pharma GmbH NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

UCB Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 7 STIPULATION TO EXTEND TIME to Answer, Move Or Otherwise Respond to Complaint to September 9, 2013 filed by Research Corporation Technologies In...
Entry #— • 2013-07-23
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move Or Otherwise Respond to Complaint to September 9, 2013 - filed by Harris FRC Corporation, Research Corporation Techno...
Entry #7 • 2013-07-19 Document →

Docket Entries

(28 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1319314.) - filed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(mdb) (Entered: 06/28/2013)

Entry #1 • 2013-06-28
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mdb) (Entered: 06/28/2013)

Entry #2 • 2013-06-28
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/30/2013. Date of Expiration of Patent: 3/17/2022.Thirty Month Stay Deadline: 11/30/2015. (mdb) (Entered: 06/28/2013)

Entry #3 • 2013-06-28
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 38,551;. (mdb) (Entered: 06/28/2013)

Entry #4 • 2013-06-28
1

Disclosure Statement pursuant to Rule 7.1 filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH identifying Corporate Parent UCB S.A., Other Affiliate UCB Holdings Inc., Other Affiliate UCB Lux S.A., Other Affiliate Fipar US Inc., Other Affiliate Medeva Ltd. for UCB Inc.; Corporate Parent UCB GmbH, Other Affiliate UCB S.A., Other Affiliate UCB Finance N.V. for UCB Pharma GmbH. (mdb) (Entered: 06/28/2013)

Entry #5 • 2013-06-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc